vs
ACCO BRANDS Corp（ACCO）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是ACCO BRANDS Corp的1.6倍（$702.9M vs $428.8M），Healthpeak Properties净利率更高（51.6% vs 5.0%，领先46.7%），ACCO BRANDS Corp同比增速更快（-4.3% vs -6.6%），过去两年ACCO BRANDS Corp的营收复合增速更高（9.3% vs 0.5%）
ACCO Brands是一家美国跨国企业，由财富品牌旗下的ACCO World与通用装订公司GBC合并组建而成，截至2025年，公司董事长兼首席执行官为Thomas W. Tedford，主营办公文具与办公用品相关业务。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
ACCO vs DOC — 直观对比
营收规模更大
DOC
是对方的1.6倍
$428.8M
营收增速更快
ACCO
高出2.3%
-6.6%
净利率更高
DOC
高出46.7%
5.0%
两年增速更快
ACCO
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $428.8M | $702.9M |
| 净利润 | $21.3M | $363.0M |
| 毛利率 | 33.6% | — |
| 营业利润率 | 9.3% | 0.7% |
| 净利率 | 5.0% | 51.6% |
| 营收同比 | -4.3% | -6.6% |
| 净利润同比 | 3.4% | 28.3% |
| 每股收益（稀释后） | $0.23 | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACCODOC
| Q1 26 | — | $702.9M | ||
| Q4 25 | $428.8M | $719.4M | ||
| Q3 25 | $383.7M | $705.9M | ||
| Q2 25 | $394.8M | $694.3M | ||
| Q1 25 | $317.4M | $702.9M | ||
| Q4 24 | $448.1M | $698.0M | ||
| Q3 24 | $420.9M | $700.4M | ||
| Q2 24 | $438.3M | $695.5M |
净利润ACCODOC
| Q1 26 | — | $363.0M | ||
| Q4 25 | $21.3M | $114.0M | ||
| Q3 25 | $4.0M | $-117.1M | ||
| Q2 25 | $29.2M | $31.7M | ||
| Q1 25 | $-13.2M | $42.8M | ||
| Q4 24 | $20.6M | $4.5M | ||
| Q3 24 | $9.3M | $85.9M | ||
| Q2 24 | $-125.2M | $146.0M |
毛利率ACCODOC
| Q1 26 | — | — | ||
| Q4 25 | 33.6% | — | ||
| Q3 25 | 33.0% | 58.6% | ||
| Q2 25 | 32.9% | 60.2% | ||
| Q1 25 | 31.4% | 61.1% | ||
| Q4 24 | 34.7% | 60.3% | ||
| Q3 24 | 32.5% | 60.0% | ||
| Q2 24 | 34.8% | 60.6% |
营业利润率ACCODOC
| Q1 26 | — | 0.7% | ||
| Q4 25 | 9.3% | 17.4% | ||
| Q3 25 | 6.8% | 9.2% | ||
| Q2 25 | 8.4% | 5.7% | ||
| Q1 25 | -2.1% | 7.7% | ||
| Q4 24 | 9.4% | -2.2% | ||
| Q3 24 | 6.2% | 14.1% | ||
| Q2 24 | -25.4% | 22.3% |
净利率ACCODOC
| Q1 26 | — | 51.6% | ||
| Q4 25 | 5.0% | 73.2% | ||
| Q3 25 | 1.0% | -16.6% | ||
| Q2 25 | 7.4% | 4.6% | ||
| Q1 25 | -4.2% | 6.1% | ||
| Q4 24 | 4.6% | 0.7% | ||
| Q3 24 | 2.2% | 12.3% | ||
| Q2 24 | -28.6% | 21.0% |
每股收益（稀释后）ACCODOC
| Q1 26 | — | $0.28 | ||
| Q4 25 | $0.23 | $0.16 | ||
| Q3 25 | $0.04 | $-0.17 | ||
| Q2 25 | $0.31 | $0.05 | ||
| Q1 25 | $-0.14 | $0.06 | ||
| Q4 24 | $0.21 | $0.02 | ||
| Q3 24 | $0.09 | $0.12 | ||
| Q2 24 | $-1.29 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $-1.2B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $664.6M | $7.8B |
| 总资产 | $2.3B | $21.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACCODOC
| Q1 26 | — | $-1.2B | ||
| Q4 25 | — | $467.5M | ||
| Q3 25 | — | $91.0M | ||
| Q2 25 | — | $89.4M | ||
| Q1 25 | — | $70.6M | ||
| Q4 24 | — | $119.8M | ||
| Q3 24 | — | $180.4M | ||
| Q2 24 | — | $106.9M |
总债务ACCODOC
| Q1 26 | — | — | ||
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B |
股东权益ACCODOC
| Q1 26 | — | $7.8B | ||
| Q4 25 | $664.6M | $7.5B | ||
| Q3 25 | $644.0M | $7.6B | ||
| Q2 25 | $637.3M | $7.9B | ||
| Q1 25 | $606.1M | $8.2B | ||
| Q4 24 | $606.1M | $8.4B | ||
| Q3 24 | $615.5M | $8.6B | ||
| Q2 24 | $617.1M | $8.8B |
总资产ACCODOC
| Q1 26 | — | $21.6B | ||
| Q4 25 | $2.3B | $20.3B | ||
| Q3 25 | $2.3B | $19.6B | ||
| Q2 25 | $2.4B | $19.8B | ||
| Q1 25 | $2.3B | $19.8B | ||
| Q4 24 | $2.2B | $19.9B | ||
| Q3 24 | $2.4B | $20.0B | ||
| Q2 24 | $2.4B | $20.2B |
负债/权益比ACCODOC
| Q1 26 | — | — | ||
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $30.6M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 3.4% |
| 现金转化率经营现金流/净利润 | 1.44× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACCODOC
| Q1 26 | — | — | ||
| Q4 25 | $30.6M | $1.3B | ||
| Q3 25 | $71.5M | $315.0M | ||
| Q2 25 | $-38.9M | $363.5M | ||
| Q1 25 | $5.5M | $279.4M | ||
| Q4 24 | $52.7M | $1.1B | ||
| Q3 24 | $92.9M | $318.2M | ||
| Q2 24 | $-25.6M | $316.2M |
自由现金流ACCODOC
| Q1 26 | — | — | ||
| Q4 25 | — | $357.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率ACCODOC
| Q1 26 | — | — | ||
| Q4 25 | — | 49.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 47.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度ACCODOC
| Q1 26 | — | 3.4% | ||
| Q4 25 | — | 124.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 105.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率ACCODOC
| Q1 26 | — | — | ||
| Q4 25 | 1.44× | 10.99× | ||
| Q3 25 | 17.88× | — | ||
| Q2 25 | -1.33× | 11.48× | ||
| Q1 25 | — | 6.52× | ||
| Q4 24 | 2.56× | 235.43× | ||
| Q3 24 | 9.99× | 3.71× | ||
| Q2 24 | — | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACCO
| Transferred At Point In Time | $421.6M | 98% |
| Transferred Over Time | $7.2M | 2% |
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
